Biochemical response to enzalutamide therapy in patients with mCRPC following docetaxel and abiraterone treatment.
M. Andreas Roeder
Honoraria - Astellas Pharma
Frederik Birkebæk Thomsen
No relevant relationships to disclose
Klaus Brasso
No relevant relationships to disclose
Per Rathenborg
No relevant relationships to disclose
Michael Borre
Honoraria - Astex Therapeutics; Janssen-Cilag
Peter Iversen
Honoraria - Astellas Pharma; Janssen-Cilag